A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure "COMMANDER HF"

Active, not recruiting

Phase 3 Results N/A


Related Links

Sources for Trial Information